Eckhard R. Podack
Corporate Officer/Principal at University of Miami
Profile
Eckhard R.
Podack was the founder of Pique Therapeutics, Inc. (founded in 2005) where he held the title of Director & Chief Scientific Officer.
He is currently a Professor at the University of Miami since 2013.
In the past, he worked as the Chief Scientific Officer at Scorpius Holdings, Inc. Dr. Podack obtained a doctorate degree from the University of Gottingen and Johann Wolfgang Goethe-Universität Frankfurt am Main in 1968.
Eckhard R. Podack active positions
Companies | Position | Start |
---|---|---|
University of Miami
University of Miami Other Consumer ServicesConsumer Services University of Miami (Florida) is a private research university with students from around the world that is focused on teaching and learning, the discovery of new knowledge, and service to the South Florida region and beyond. The university was founded in 1925 and it is headquartered in Coral Gables, FL. | Corporate Officer/Principal | - |
Former positions of Eckhard R. Podack
Companies | Position | End |
---|---|---|
Pique Therapeutics, Inc.
Pique Therapeutics, Inc. BiotechnologyHealth Technology Pique Therapeutics, Inc. develops therapeutic vaccines for the treatment of cancer. It focused on the development of new therapies to treat non-small cell lung, pancreatic, colorectal, head and neck cancer. The company was founded by Eckhard R. Podack in 2005 and is headquartered in Durham, NC. | Founder | - |
SCORPIUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Eckhard R. Podack
University of Gottingen | Doctorate Degree |
Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SCORPIUS HOLDINGS, INC. | Health Technology |
Private companies | 1 |
---|---|
Pique Therapeutics, Inc.
Pique Therapeutics, Inc. BiotechnologyHealth Technology Pique Therapeutics, Inc. develops therapeutic vaccines for the treatment of cancer. It focused on the development of new therapies to treat non-small cell lung, pancreatic, colorectal, head and neck cancer. The company was founded by Eckhard R. Podack in 2005 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Eckhard R. Podack